ArticleJournal of evaluation in clinical practice2025
Cross-Sectional Analysis of Research and Non-Research Payments From the Medical Device Industry to Healthcare Professionals and Organisations in Japan in 2022.
Article in Journal of evaluation in clinical practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
rationaleFinancial relationships between healthcare professionals (HCPs), healthcare organisations (HCOs) and the medical device industry in Japan may lead to conflicts of interest. Limited transparency in these relationships has raised concerns regarding their potential influence on clinical decision-making and patient care. AIMS AND
objectivesThis study aimed to assess the scope and magnitude of financial payments from medical device companies to HCPs and HCOs in Japan, focusing on publicly disclosed data from the 2022 fiscal year.
methodsA cross-sectional analysis of publicly available payment disclosures from 169 medical device companies, including all members of the Japan Federation of Medical Devices Associations (JFMDA) and several major non-JFMDA affiliated companies, was conducted. Descriptive statistics were calculated to summarise payment data.
resultsOf the 169 medical device companies, 32.5% (55 companies) did not disclose payment information and 6 companies disclosed payment records in aggregated amounts with their group companies, leaving 108 companies for analysis. In total, $245.2 million in payments were made in 2022, with only 23.9% ($58.7 million) to research and development. Of the total, 34.6% ($84.9 million) was allocated to non-research payments to HCOs for sponsoring HCOs' activities, and 19.6% ($49.0 million) were paid for lecturing and consulting fees, typically to individual HCPs. More than 80% of companies allocated a greater share of payments to non-research activities than to research.
conclusionThis study reveals substantial financial relationships between medical device companies and HCPs/HCOs in Japan, predominantly for non-research purposes. Improved transparency regulations, including a uniform, government-run database, are necessary to better oversee these financial interactions with medical device industry in Japan.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.